The Application of Overactive Bladder Symptom Score (OABSS) in Response to Treatment in Chinese Population

Trial Profile

The Application of Overactive Bladder Symptom Score (OABSS) in Response to Treatment in Chinese Population

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 01 Jan 2014 Status changed from recruiting to completed according to results published in the Chinese Medical Journal.
    • 23 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top